• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
In the last 5 minutes
In the last hour
Yesterday
Here's Why Orphazyme Stock Is Imploding Today The Motley Fool17:40 18-Jun-21
DoH, FDA cited for tobacco control The Manila Times17:08 18-Jun-21
Gene Munster: FDA approval is the key to Apple’s health ambitions Philip-Elmer-De-Witt's Apple 3.017:06 18-Jun-21
Orphazyme Tumbles Back To Earth As FDA Rejects Arimoclomol Scrip Pharma Intelligence15:41 18-Jun-21
Is It Too Late to Buy Biogen Stock? The Motley Fool14:26 18-Jun-21
In the last 7 days
BIO 2021 Notebook: Biogen CEO On Corporate Responsibility Scrip Pharma Intelligence23:53 17-Jun-21
FDA Approves a Nasal Antihistamine for Nonprescription Use U.S. Food and Drug Administration (Press Release)21:36 17-Jun-21
FDA In Brief: FDA Announces Qualification of a Medical Device Development Tool to Help Assess… U.S. Food and Drug Administration (Press Release)18:53 17-Jun-21
FDA In Brief: FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking… U.S. Food and Drug Administration (Press Release)18:23 17-Jun-21
Why Agenus Stock Is Marching Higher Today The Motley Fool18:03 17-Jun-21
Immunobridging still feasible, FDA says Taipei Times17:11 17-Jun-21
The FDA is in desperate need of some soul-searching The Washington Post16:59 17-Jun-21
Why Nano-X Imaging Stock Just Jumped 15% The Motley Fool16:52 17-Jun-21
view more headlines
19 Jun 10:06

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.